FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3002385314> ?p ?o ?g. }

• W3002385314 endingPage "1787" @default.
• W3002385314 startingPage "1783" @default.
• W3002385314 abstract "Vaso-occlusive crisis (VOC) is the primary cause of morbidity and hospitalization in sickle cell disease (SCD); however, only 4 therapies (hydroxyurea, l-glutamine, crizanlizumab, and voxeletor) are currently approved in SCD. These agents limit the duration, severity, and frequency of crises. Activation of coagulation is a hallmark of SCD. Studies in animal models of SCD have shown that coagulation contributes to the chronic inflammation and end-organ damage associated with the disease; however, it is unknown whether coagulation directly contributes to the microvascular stasis that causes VOC. Herein, we demonstrate that inhibition of tissue factor (TF) and the downstream coagulation proteases factor Xa and thrombin significantly attenuates heme-induced microvascular stasis in mouse models of VOC. Pharmacologic inhibition of the principal thrombin receptor, protease activated receptor-1 (PAR-1), as well as deficiency of PAR-1 in all nonhematopoietic cells, also reduces stasis in sickle mice. PAR-1 deficiency was associated with reduced endothelial von Willebrand factor expression, which has been shown to mediate microvascular stasis. In addition, TF inhibition reduces lung vaso-occlusion in sickle mice mediated by arteriolar neutrophil-platelet microemboli. In sum, these results suggest that prophylactic anticoagulation might attenuate the incidence of VOC." @default.
• W3002385314 created "2020-01-30" @default.
• W3002385314 creator A5012545488 @default.
• W3002385314 creator A5013288442 @default.
• W3002385314 creator A5013658598 @default.
• W3002385314 creator A5033993786 @default.
• W3002385314 creator A5043649821 @default.
• W3002385314 creator A5053383529 @default.
• W3002385314 creator A5079756733 @default.
• W3002385314 creator A5082575546 @default.
• W3002385314 creator A5090702301 @default.
• W3002385314 creator A5090785817 @default.
• W3002385314 date "2020-05-14" @default.
• W3002385314 modified "2023-10-16" @default.
• W3002385314 title "Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease" @default.
• W3002385314 cites W1811402656 @default.
• W3002385314 cites W1966126000 @default.
• W3002385314 cites W1978407650 @default.
• W3002385314 cites W1984887661 @default.
• W3002385314 cites W1992525172 @default.
• W3002385314 cites W1993862026 @default.
• W3002385314 cites W1995931298 @default.
• W3002385314 cites W2002456771 @default.
• W3002385314 cites W2016192896 @default.
• W3002385314 cites W2019381418 @default.
• W3002385314 cites W2019874022 @default.
• W3002385314 cites W2029724982 @default.
• W3002385314 cites W2092338209 @default.
• W3002385314 cites W2112671019 @default.
• W3002385314 cites W2120707628 @default.
• W3002385314 cites W2158519357 @default.
• W3002385314 cites W2174434727 @default.
• W3002385314 cites W2402408978 @default.
• W3002385314 cites W2516744470 @default.
• W3002385314 cites W2551990299 @default.
• W3002385314 cites W2559643145 @default.
• W3002385314 cites W2605277819 @default.
• W3002385314 cites W2732958242 @default.
• W3002385314 cites W2800995050 @default.
• W3002385314 cites W2803678042 @default.
• W3002385314 cites W2885485060 @default.
• W3002385314 cites W2984750677 @default.
• W3002385314 cites W3166119736 @default.
• W3002385314 doi "https://doi.org/10.1182/blood.2019003543" @default.
• W3002385314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7225686" @default.
• W3002385314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31977004" @default.
• W3002385314 hasPublicationYear "2020" @default.
• W3002385314 type Work @default.
• W3002385314 sameAs 3002385314 @default.
• W3002385314 citedByCount "31" @default.
• W3002385314 countsByYear W30023853142020 @default.
• W3002385314 countsByYear W30023853142021 @default.
• W3002385314 countsByYear W30023853142022 @default.
• W3002385314 countsByYear W30023853142023 @default.
• W3002385314 crossrefType "journal-article" @default.
• W3002385314 hasAuthorship W3002385314A5012545488 @default.
• W3002385314 hasAuthorship W3002385314A5013288442 @default.
• W3002385314 hasAuthorship W3002385314A5013658598 @default.
• W3002385314 hasAuthorship W3002385314A5033993786 @default.
• W3002385314 hasAuthorship W3002385314A5043649821 @default.
• W3002385314 hasAuthorship W3002385314A5053383529 @default.
• W3002385314 hasAuthorship W3002385314A5079756733 @default.
• W3002385314 hasAuthorship W3002385314A5082575546 @default.
• W3002385314 hasAuthorship W3002385314A5090702301 @default.
• W3002385314 hasAuthorship W3002385314A5090785817 @default.
• W3002385314 hasBestOaLocation W30023853141 @default.
• W3002385314 hasConcept C126322002 @default.
• W3002385314 hasConcept C181199279 @default.
• W3002385314 hasConcept C182220744 @default.
• W3002385314 hasConcept C186738567 @default.
• W3002385314 hasConcept C203014093 @default.
• W3002385314 hasConcept C2776246508 @default.
• W3002385314 hasConcept C2776914184 @default.
• W3002385314 hasConcept C2777292125 @default.
• W3002385314 hasConcept C2778382381 @default.
• W3002385314 hasConcept C2779394231 @default.
• W3002385314 hasConcept C54173615 @default.
• W3002385314 hasConcept C55493867 @default.
• W3002385314 hasConcept C71924100 @default.
• W3002385314 hasConcept C86803240 @default.
• W3002385314 hasConcept C89560881 @default.
• W3002385314 hasConcept C98274493 @default.
• W3002385314 hasConceptScore W3002385314C126322002 @default.
• W3002385314 hasConceptScore W3002385314C181199279 @default.
• W3002385314 hasConceptScore W3002385314C182220744 @default.
• W3002385314 hasConceptScore W3002385314C186738567 @default.
• W3002385314 hasConceptScore W3002385314C203014093 @default.
• W3002385314 hasConceptScore W3002385314C2776246508 @default.
• W3002385314 hasConceptScore W3002385314C2776914184 @default.
• W3002385314 hasConceptScore W3002385314C2777292125 @default.
• W3002385314 hasConceptScore W3002385314C2778382381 @default.
• W3002385314 hasConceptScore W3002385314C2779394231 @default.
• W3002385314 hasConceptScore W3002385314C54173615 @default.
• W3002385314 hasConceptScore W3002385314C55493867 @default.
• W3002385314 hasConceptScore W3002385314C71924100 @default.
• W3002385314 hasConceptScore W3002385314C86803240 @default.
• W3002385314 hasConceptScore W3002385314C89560881 @default.
• W3002385314 hasConceptScore W3002385314C98274493 @default.

• next